Text Size

New Horizons Forum

The 5th Annual New Horizons Forum: speeding the development of new therapies and diagnostics for glaucoma patients. Register Now »


January 29, 2016 — The Palace Hotel, San Francisco, California

The centerpiece of Glaucoma 360, the New Horizons Forum unites key clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment.

Launched in 2012 by the Glaucoma Research Foundation, this catalyst meeting is designed to bring the essential components together in order to speed the translation of new ideas into clinical practice.


Keynote Speaker
2016 Drs. Henry and Frederick Sutro Memorial Lecture

Richard A. Lewis, MD
Co-Founder, Grutzmacher, Lewis & Sierra Surgical Eye Specialists
Former Director of Glaucoma, University of California, Davis
President, American Society of Cataract and Refractive Surgery
Past President, American Glaucoma Society.

What others are saying about New Horizons Forum:

"New Horizons is an interdisciplinary meeting and ophthalmologists can learn so much from colleagues with a different perspective. Our ophthalmic community is at its most vibrant when we collaborate and share ideas. New Horizons is where this happens."
- Ruth D. Williams, MD, President, Wheaton Eye Clinic

"The best meeting to learn about what's really new in glaucoma."
- Ahmad A. Aref, MD, Illinois Eye and Ear Infirmary

"A great introduction to emerging technologies together with the opportunity to meet the innovators."
- John Maroney, CEO, ForSight Vision 5

Who should attend:

  • Early-stage company CEOs and executives
  • Business Development and other representatives from companies that offer pharmaceuticals, devices, drug delivery, and IOP monitoring for glaucoma patients
  • Key Opinion Leaders and Leading Ophthalmologists
  • Industry Executives
  • Venture Capitalists
  • Representatives from Clinical Research Organizations
  • Scientific innovators



Founder and Co-Chair

Adrienne Graves, PhD
Independent Director: Aerpio Therapeutics, Akorn, Inc., Encore Vision, Inc., Envisia Therapeutics, Nicox S.A., and TearLab Corporation


Founder and Co-Chair

Andrew G. Iwach, MD
Executive Director
Glaucoma Center of San Francisco

New Horizons Advisory Board »

Nationally and internationally respected leaders in the field of glaucoma, business, and medical innovation provide leadership for the second annual Glaucoma 360 New Horizons Forum. The Advisory Board is actively involved, along with the Program Committee, in planning the meeting and recommending engaging speakers, noteworthy panelists, and timely topics. View our 2016 Advisory Board and Program Committee »


The 5th annual New Horizons Forum, a full-day program, will take place January 29, 2016 at The Palace Hotel in San Francisco.

7:30 AM - Registration, Breakfast, and Exhibits

8:00 AM to 5:30 PM - Program

5:30 PM to 7:00 PM - Reception

New Horizons Exhibit Hall — 7:30 AM to 7:00 PM

Download the 2015 New Horizons Forum program (PDF) »

Sponsorship Opportunities

Download the 2016 New Horizons Forum Sponsorship Opportunities or contact Aileen Trieu at 415-986-3162 for more information.



All Glaucoma 360 events are held at the historic Palace Hotel in San Francisco, California. The Palace is an iconic landmark venue featuring timeless creations such as the Garden Court's stained glass dome and a 1909 Maxfield Parrish mural in the Pied Piper Bar. The Palace Hotel is a full-service destination that offers elegant accommodations, esteemed restaurants and opulent meeting spaces.

The Palace Hotel
2 New Montgomery St, San Francisco, CA 94105
Phone: (415) 512-1111

Learn More and Register


Register Online »

Learn More about New Horizons Forum »

See testimonials from leaders in ophthalmology on our Glaucoma 360 Video Channel »

For more information, please email Aileen Trieu at Glaucoma Research Foundation, or call (415) 986-3162.

Photos from the 2015 New Horizons Forum

Proceeds from the New Horizons Forum benefit the Glaucoma Research Foundation for use in our grant-making and other operational priorities.

Last reviewed on September 30, 2015

Was this helpful? Yes No